FDA Learned Consumer Protection Lesson From 2004 Flu Scare
This article was originally published in The Tan Sheet
Executive Summary
The roster of teams FDA assembled to respond to the 2009-N1H1 flu outbreak includes a consumer protection group to identify potentially dangerous products marketed as cures for the virus
You may also be interested in...
FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply
FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney
FDA Pursues Consumer Products With Questionable Flu Treatment Claims
FDA continues its efforts to protect consumers from the ongoing H1N1 flu outbreak, as well as from opportunistic marketers selling potentially deceptive "cures" for the virus
MedKit Development For Flu Outbreak Is “Part Of The Discussion”– Sharfstein
The spread of the 2009-H1N1 flu virus in the U.S. is not prompting FDA to accelerate work on a proposed program for home stockpiling of antiviral drugs, acting Commissioner Josh Sharfstein says